Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test.
about
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsHPV-Testing in Follow-up of Patients Treated for CIN2+ LesionsCurrent Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers.HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system.Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study.Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample studySignificantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.A review of methods for detect human Papillomavirus infectionDifferential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays.Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.Human papillomavirus testing and genotyping in cervical screening.Understanding HPV tests and their appropriate applications.Human papillomavirus prevalence and genotype distribution among young women and men in Maputo city, Mozambique.Molecular approaches for HPV genotyping and HPV-DNA physical status.Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening.Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders.Detection of fungal DNA in peritoneal fluids by a PCR DNA low-density microarray system and quantitation of serum (1-3)-β-D-glucan in the diagnosis of peritoneal candidiasis.Use of the NucliSENS EasyQ HPV assay in the management of cervical intraepithelial neoplasia.
P2860
Q24198236-F6B9B4C0-F5F0-4EEE-B434-206C74428F35Q26771420-E52B1D58-2D3C-4DC6-8FA9-91F7B7D290D9Q28072364-8A9C283F-9836-4BF8-807F-886E019059ADQ34006684-CFBA19A2-7015-416F-AAAA-542C30589FE7Q35342179-A329B7DF-C6BE-4E12-B385-78C0702A22CCQ35898888-C444C147-9B61-4733-94FB-E133D8340B0EQ36083187-043EECF5-4A01-4931-99BD-98D47E9F28B5Q36092294-A41FF8B9-1DDE-4482-83A7-4FC0718C19E1Q36427451-F546E519-C3A8-48C2-85EA-678B948CBB67Q37363392-9AFC91ED-D3FB-4C42-ABA3-423C680ED5B6Q37496183-982B4825-2312-471E-915F-8B4F8466DDC9Q37909359-006CA707-3183-42EE-A8B1-51AB16E74B3DQ38133612-D0D97FEC-0F03-4E12-A671-4218BBF9041BQ38674920-36187EC4-773C-4467-972A-60E35F986956Q39120200-A5B3AE26-880E-40B2-B323-7C21B8699EA3Q39170424-58CE22C2-AD12-4E93-8AA6-09F11EFED006Q40043990-A5DBCCF0-EDF1-41D4-A3D1-5431F185F699Q40116201-0BE3499D-D561-45D7-BD0E-06A1D20196F6Q41581019-A672DC86-C982-438C-AC80-AC5BF82C61E9Q42252306-E7079529-ADFE-4238-B268-D9B2FF9E272E
P2860
Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Clinical performance of the CL ...... ith the hybrid capture 2 test.
@en
Clinical performance of the CL ...... ith the hybrid capture 2 test.
@nl
type
label
Clinical performance of the CL ...... ith the hybrid capture 2 test.
@en
Clinical performance of the CL ...... ith the hybrid capture 2 test.
@nl
prefLabel
Clinical performance of the CL ...... ith the hybrid capture 2 test.
@en
Clinical performance of the CL ...... ith the hybrid capture 2 test.
@nl
P356
P1476
Clinical performance of the CL ...... with the hybrid capture 2 test
@en
P2093
Ana Oliveira
P304
P356
10.1002/JMV.21952
P577
2011-02-01T00:00:00Z